NICE TA954: for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments. NHSE commissioned. (Decision date - April 2024)
Red Drug Classifications
8. NHS England commissioned – to be used in line with NHSE commissioning intentions
